RETRACTED: Relationship between serum TGF- β 1, MMP-9 and IL-1β and pathological features and prognosis in breast cancer
Open Access
- 12 January 2023
- journal article
- retracted article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 1095338
Abstract
To investigate the levels of serum transforming growth factor-β 1 (TGF-β1), Matrix metalloproteinase-9 (MMP-9) and Interleukin-1 β (IL-1 β) in breast cancer (BC), and analyzing their relationship with pathological features and prognosis. Retrospective analysis of 86 subjects with BC (BC subgroup) and another 50 healthy subjects (control subgroup) during the same period were included. The clinical data were collected. In this research, in BC subgroup, The levels of serum TGF- β 1, MMP-9 and IL-1 β were significantly higher than those in control subgroup. The levels of TGF- β 1 and MMP-9 in serum of BC subjects was correlated with clinical stage, histological grade, lymph node metastasis and molecular classification, but not with age, tumor size and menopausal status. The level of serum IL-1 β was related to tumor size, clinical stage, histological grade and lymph node metastasis. Multivariate Logistic regression analysis showed that the high level of serum TGF- β1 and MMP-9 was independent risk factors for BC. High level of serum IL-1 β was not an independent risk factor for BC. The 3-year disease-free survival rate in high TGF- β1 subgroup and high MMP-9 subgroup was significantly lower than that in low TGF- β 1 subgroup and low MMP- 9 subgroup. To conclude, serum TGF- β 1, MMP-9 and IL-1β are highly expressed in BC, and the subjects with elevated serum levels of TGF- β 1 and MMP-9 suggests poor prognosis.Keywords
This publication has 29 references indexed in Scilit:
- TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and CancerInternational Journal of Molecular Sciences, 2018
- Demethylation of Repressor Element-1 Silencing Transcription (REST) Suppresses the Malignant Phenotype of Breast Cancer via MMP9Oncology Research, 2017
- Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential TherapyScientific Reports, 2016
- Incidence and Mortality and Epidemiology of Breast Cancer in the WorldAsian Pacific Journal of Cancer Prevention, 2016
- Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironmentOncotarget, 2015
- Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In SituJAMA Oncology, 2015
- The SIX1-EYA transcriptional complex as a therapeutic target in cancerExpert Opinion on Therapeutic Targets, 2014
- MiR-7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 PathwayStem Cells, 2014
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Airway smooth muscle: A modulator of airway remodeling in asthmaJournal of Allergy and Clinical Immunology, 2005